Breast Cancer Treatment Studies
Breast Cancer Treatment Studies is a research topic within Cancer Research. Science Explorer counts 54k research works in it since 1950. 13.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on molecular research, treatment response, and prognostic markers in breast cancer. It covers topics such as gene expression patterns, molecular subtypes, neoadjuvant therapy, radiotherapy, and the impact of hormone receptors on survival. The papers also discuss the development of clinical practice guidelines for breast cancer management.
- Gene Expression
- Breast Tumours
- Treatment Response
- Molecular Subtypes
- Prognostic Markers
- Neoadjuvant Therapy
- Radiotherapy
- Hormone Receptors
- Survival Analysis
- Clinical Practice Guidelines
- Research works
- 54k fractional, since 1950
- In the world top 10%
- 7.1k per year above
- Top-10% rate
- 13.1% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +17% the tick is no change
Which countries lead Breast Cancer Treatment Studies research?
By volume, the United States and China publish the most (2.2k and 1.6k works in 2022–2025).
By volume, 2022–2025
- 1 United States 2.2k works
- 2 China 1.6k works
- 3 India 539 works
- 4 United Kingdom 508 works
- 5 Italy 421 works
- 6 Japan 350 works
- 7 Germany 337 works
- 8 South Korea 309 works
- 9 Spain 279 works
- 10 France 241 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Breast Cancer Treatment Studies research?
By volume in 2022–2025, Memorial Sloan Kettering Cancer Center publishes the most Breast Cancer Treatment Studies research, followed by The University of Texas MD Anderson Cancer Center and Chinese Academy of Medical Sciences & Peking Union Medical College.
By volume, 2022–2025
- 1 Memorial Sloan Kettering Cancer CenterUnited States 90 works
- 2 The University of Texas MD Anderson Cancer CenterUnited States 87 works
- 3 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 65 works
- 4 University of North Carolina at Chapel HillUnited States 53 works
- 5 Harvard UniversityUnited States 38 works
- 6 Fudan University Shanghai Cancer CenterChina 37 works
- 7 Sun Yat-sen UniversityChina 33 works
- 8 Istituti di Ricovero e Cura a Carattere ScientificoItaly 31 works
- 9 All India Institute of Medical SciencesIndia 31 works
- 10 Dana-Farber Cancer InstituteUnited States 31 works
Who are the leading researchers in Breast Cancer Treatment Studies?
The most-cited researchers publishing on Breast Cancer Treatment Studies include Mike Clarke, Walter C. Willett and Hermann Brenner.
- 1 Mike Clarke United Kingdom 7.5k citations
- 2 Walter C. Willett United States 6.8k citations
- 3 Hermann Brenner Germany 5.8k citations
- 4 Ahmedin Jemal United States 4.9k citations
- 5 Charles M. Perou United States 4.2k citations
- 6 Gordon B. Mills United States 3.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Breast Cancer Treatment Studies research done?
The largest centres of Breast Cancer Treatment Studies research in 2022–2025 are New York (United States), Seoul (South Korea), Beijing (China) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Rozzano.
Largest cities, 2022–2025
Where it is the local speciality
- RozzanoIT · 21.2 works15×
Location quotient: how much more of its research is in Breast Cancer Treatment Studies than the world average.
Where is the best place to study Breast Cancer Treatment Studies?
Among universities, judged by research, Humanitas University, Institute of Cancer Research and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Humanitas UniversityItaly | 71.1 | 30.6% | 12.8× | 9 | +173.0% |
| 2 | Institute of Cancer ResearchUnited Kingdom | 57.2 | 26.1% | 32.4× | 10 | -15.5% |
| 3 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 55.4 | 13.2% | 7.1× | 65 | +77.7% |
| 4 | Shanghai Medical College of Fudan UniversityChina | 54.3 | 18.4% | 18.4× | 14 | +63.8% |
| 5 | Ulsan CollegeSouth Korea | 53.0 | 15.6% | 12.1× | 11 | +110.6% |
| 6 | Royal College of Surgeons in IrelandIreland | 52.6 | 14.5% | 11.7× | 9 | +98.5% |
| 7 | Harbin Medical UniversityChina | 52.4 | 24.9% | 8.6× | 16 | -12.7% |
| 8 | University of UlsanSouth Korea | 50.7 | 14.9% | 9.0× | 15 | +83.9% |
| 9 | Harvard UniversityUnited States | 49.3 | 22.8% | 3.2× | 38 | +40.2% |
| 10 | University of MilanItaly | 45.6 | 30.1% | 2.9× | 18 | +1.7% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Breast Cancer Treatment Studies research growing?
Output in 2018–2022 was 17% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Breast Cancer Treatment Studies.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.